FindTrial
Sign In

A study on increased blood sugar levels after use of Dexamethasone (Steroid) in Cancer Patients

Dexamethasone Induced Hyperglycemia in Cancer Patients: A Prospective Cohort Study in a Tertiary Care Facility - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/10/058185
Enrollment
122
Registered
2023-10-03
Start date
Unknown
Completion date
Unknown
Last updated
2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C00-D49- Neoplasms

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

NIL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Newly diagnosed with Cancer, Non-diabetic Patients prescribed with Dexamethasone (Study Cohort) Patients not being prescribed with Dexamethasone (Reference Cohort)

Exclusion criteria

Exclusion criteria: Out-patients, Diabetic, Patients who already have a history with Dexamethasone

Design outcomes

Primary

MeasureTime frame
Incidence of Dexamethasone induced hyperglycemia. Timepoint: 24th hour after administration of one dose of Dexamethasone.—

Secondary

MeasureTime frame
Factors affecting dexamethasone induced hyperglycemiaTimepoint: 24th hour after administration of one dose of Dexamethasone.—

Countries

India

Contacts

Public ContactDr Sonal Sekhar M

Manipal College of Pharmaceutical Sciences

sonal.sekhar@manipal.edu7411338846

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026